-
動態
6月3日16:30，仁醫醫療三人團隊前往海德堡大學附屬醫院，拜訪婦產科主任 Zivanovic教授及其團隊。教授的助理早早在會議室等候，為我們準備了咖啡、飲品和甜鹹點心，細致周到。Zivanovic 教授與三位年輕的婦科腫瘤專業進修醫生一同出席了會談。在我們簡要介紹了仁醫醫療的發展背景與合作模式後，Dr. Herrmann與 Dr. Köhlerxiangwomenxitongjieshaoletamentuanduidefukezhongliuzhuankejinxiuxiangmu。gaixiangmujujiaoyufukeexingzhongliudelinchuangyukeyannenglipeiyang，jinxiangyiwanchengfukezhuankerenzhengdeyishengkaifangshenqing。xiangmuzongzhouqiweisinian：前兩年進修醫生在德國癌症研究中心（DKFZ）從事科研工作，並參與每周一次的婦科腫瘤多學科會診；後兩年則在海德堡大學附屬醫院的相關臨床科室輪轉，全麵提升婦科惡性腫瘤診療能力。Zivanovic教授強調，這是一個高度專業化的培訓路徑，符合當前醫學日益“亞專科化”的發展趨勢。Zivanovic教授自2023年起擔任海德堡大學附屬醫院婦產科主任，加入前曾長期在紐約斯隆·凱kai特te林lin癌ai症zheng研yan究jiu所suo執zhi業ye。他ta擁yong有you國guo際ji化hua的de臨lin床chuang與yu科ke研yan背bei景jing，致zhi力li於yu將jiang先xian進jin的de腫zhong瘤liu治zhi療liao理li念nian融rong入ru德de國guo婦fu產chan科ke的de診zhen療liao實shi踐jian。他ta所suo領ling導dao的de婦fu科ke腫zhong瘤liu中zhong心xin是shi德de國guo癌ai症zheng學xue會hui認ren證zheng的de高gao水shui平ping診zhen療liao與yu研yan究jiu單dan位wei，核he心xin關guan注zhu卵luan巢chao癌ai、子宮內膜癌、宮頸癌等多種婦科惡性腫瘤的個體化治療與綜合管理，強調精準醫療、創新臨床路徑與多學科合作。在交流中，Zivanovic 教jiao授shou高gao度du肯ken定ding了le仁ren醫yi醫yi療liao的de理li念nian。他ta表biao示shi，近jin年nian來lai在zai國guo際ji會hui議yi上shang頻pin頻pin見jian到dao中zhong國guo同tong道dao在zai婦fu科ke腫zhong瘤liu領ling域yu的de突tu出chu貢gong獻xian，但dan苦ku於yu缺que乏fa合he適shi的de渠qu道dao，難nan以yi實shi現xian深shen入ru交jiao流liu。他ta坦tan言yan，自zi己ji每mei天tian都dou收shou到dao不bu少shao來lai自zi中zhong國guo學xue生sheng、醫生和研究人員的聯係請求，但由於數量龐大、背bei景jing各ge異yi，確que實shi難nan以yi甄zhen別bie與yu統tong籌chou，因yin此ci看kan到dao我wo們men這zhe樣yang的de專zhuan業ye機ji構gou介jie入ru合he作zuo推tui進jin，讓rang他ta感gan到dao非fei常chang安an心xin與yu期qi待dai。他ta希xi望wang今jin後hou能neng借jie助zhu仁ren醫yi醫yi療liao與yu中zhong國guo開kai展zhan更geng直zhi接jie、更深入的合作交流。
At 16:30 of June 3rd, the team of three from Gloryren went to Heidelberg University Hospital to visit Prof. Zivanovic, Director of the Department of Gynecology and Obstetrics, and his team. Ms. Önal, Prof. Zivanovic’s assistant, was waiting in the conference room, kindly preparing coffee, other drinks, and some sweet and savory snacks for us. Prof. Zivanovic attended the meeting with three fellows. After our brief introduction to Gloryren's background and cooperation model, Dr. Herrmann and Dr. Köhler provided a detailed presentation on the structured fellowship program for gynecologic oncology. This program focuses on the training of both clinical and research competencies in gynecologic malignancies and is open exclusively to certified specialist in gynecology. The total duration of the program is four years: in the first two years, fellows engage in research at the German Cancer Research Center (DKFZ) and participate in weekly multidisciplinary gynecologic tumor boards; in the last two years, they rotate in relevant clinical departments at Heidelberg University Hospital to comprehensively enhance their diagnostic and treatment skills for gynecologic malignancies. Prof. Zivanovic emphasized that this is a highly specialized training pathway that aligns with the current trend toward increasing "subspecialization" in medicine. Since 2023, Prof. Zivanovic has served as the Director of Gynecology and Obstetrics at Heidelberg University Hospital. Before joining Heidelberg University Hospital, he practiced for many years at Memorial Sloan Kettering Cancer Center in New York. With extensive international clinical and research experience, Prof. Zivanovic is dedicated to integrating advanced oncology treatment concepts into the practice of gynecology in Germany. The Center for Gynecological Cancer led by him is a high-level treatment and research center, certified by the German Cancer Society (DKG). It focuses on the individualized treatment and comprehensive management of various gynecologic malignancies such as ovarian cancer, endometrial cancer, and cervical cancer, with a strong emphasis on precision medicine, innovative clinical pathways, and multidisciplinary collaboration. During the meeting, Prof. Zivanovic highly acknowledged with the concept of Gloryren. He shared that in recent years, he has repeatedly noticed remarkable contributions from Chinese colleagues in the field of gynecologic oncology at international conferences, but due to the limited access, he found it difficult to have in-depth exchanges with them. Therefore, with the help of a professional institution like Gloryren, he has gained a strong sense of confidence and now holds high expectations for the collaboration. He hopes to establish more direct and in-depth exchanges with China via Gloryren in the future.
